This inventor holds 1 USPTO granted patent. Top assignee: Duke University. Active years: 2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2016
Title: Inventor Rasheed A. Gbadegesin: Pioneering Research in Hereditary Kidney Disease
Introduction
Rasheed A. Gbadegesin, based in Durham, NC, is an innovative inventor making significant contributions to the field of genetics and medicine. With one patented invention, Gbadegesin has focused his research on understanding and diagnosing hereditary kidney diseases and urinary tract malformations.
Latest Patents
Gbadegesin's patent revolves around isolated nucleotides encoding polypeptides with mutations that lead to amino acid substitutions linked to hereditary kidney disease or malformation of the urinary tract. This groundbreaking work provides constructs, cells, probes, and inhibitory molecules that comprise these mutations, laying the foundation for screening assays intended for finding candidate agents that may treat or reverse these conditions. Furthermore, his patent includes methods for diagnosing individuals likely to develop these diseases or identifying carriers.
Career Highlights
Rasheed A. Gbadegesin is associated with Duke University, where he conducts his research and further develops his innovative ideas. His work not only contributes to academic knowledge but also has practical implications for diagnosing and treating hereditary diseases, showcasing his commitment to improving patient outcomes through scientific advancements.
Collaborations
Gbadegesin collaborates closely with his coworker, Michelle Winn, among others, to enhance the depth and reach of his research. Their collaborative efforts aim to translate complex genetic findings into actionable medical diagnostics and therapeutic interventions.
Conclusion
Rasheed A. Gbadegesin stands out as a notable inventor in the field of genetics, particularly in the context of hereditary kidney diseases. His patent represents a significant advancement in the understanding and management of these complex conditions, and his affiliation with Duke University allows for ongoing exploration and development in this vital area of healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile